Agilon Health, Inc. (AGL) Revenue History
Annual and quarterly revenue from 2019 to present
AGL Revenue Over Time (2019–2025)
AGL Revenue Growth History
5 of 6 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- +53.4%
- FY2021 revenue growth
- +24.9%
- FY2022 revenue growth
- +57.0%
- FY2023 revenue growth
- +80.7%
- FY2024 revenue growth
- +40.4%
- FY2025 revenue growth
- -2.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.49B | +7.2% |
| Q1 2026 | $1.42B | -7.3% |
| Q4 2025 | $1.57B | +3.1% |
| Q3 2025 | $1.44B | -1.1% |
| Q2 2025 | $1.39B | -5.9% |
| Q1 2025 | $1.53B | -4.5% |
| Q4 2024 | $1.52B | +86.7% |
| Q3 2024 | $1.45B | +27.6% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
AGL's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
AGL Revenue Analysis (2019–2025)
Current Revenue & Growth
As of October 3, 2026, Agilon Health, Inc. (AGL) generated trailing twelve-month (TTM) revenue of $5.92 billion, reflecting solid growth of +7.2% year-over-year. The most recent quarter (Q2 2026) recorded $1.49 billion in revenue, up 5.2% sequentially.
Historical Growth Trajectory
AGL's 5-year compound annual growth rate (CAGR) stands at +37.2%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +35.4% is below the 5-year average, signalling a growth deceleration in recent years. Agilon Health, Inc.'s highest annual revenue of $6.06 billion was recorded in 2024.
Revenue by Segment
AGL's revenue is primarily driven by Medical Services (100%), and Other Operating (0%). With over half of revenue concentrated in Medical Services, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including CNC (+8.7% YoY), HUM (+18.3% YoY), and CVS (+7.4% YoY) — AGL has underperformed the peer group in revenue growth. Compare AGL vs CNC →
AGL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AGLCurrent | $5.9B | +7.2% | +37.2% | -7.1% | |
 CNC | $194.8B | +8.7% | +11.9% | -3.9% | |
 HUM | $129.7B | +18.3% | +10.9% | 1.1% | |
 CVS | $402.1B | +7.4% | +8.4% | 2.6% | |
 ELV | $199.1B | +6.3% | +10.3% | 4.1% | |
 MOH | $45.4B | +2.6% | +18.5% | 1.7% |
AGL Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.93B | -2.1% | $-188,614,999 | -3.2% | $-421,076,000 | -7.1% |
| 2024 | $6.06B | +40.4% | $4.8M | 0.1% | $-292,130,000 | -4.8% |
| 2023 | $4.32B | +80.7% | $69.7M | 1.6% | $-232,133,000 | -5.4% |
| 2022 | $2.39B | +57.0% | $111.4M | 4.7% | $-105,378,000 | -4.4% |
| 2021 | $1.52B | +24.9% | $65.7M | 4.3% | $-372,242,000 | -24.5% |
| 2020 | $1.22B | +53.4% | $94.2M | 7.7% | $-56,673,000 | -4.7% |
| 2019 | $794.4M | - | $28.5M | 3.6% | $-106,574,000 | -13.4% |
AGL Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AGL — Frequently Asked Questions
Quick answers to the most common questions about buying AGL stock.
Is AGL's revenue growth accelerating or slowing?
AGL revenue growth is holding steady at +7.2% year-over-year. TTM revenue is $5.9B. The current growth rate closely tracks the 5-year CAGR of +37.2%, signalling consistent execution.
What is AGL's revenue history from 2019 to 2026?
Agilon Health, Inc. (AGL) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $5.9B, growing at +7.2% YoY. The 5-year CAGR is +37.2%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is AGL's long-term revenue growth rate (CAGR)?
Agilon Health, Inc.'s 5-year revenue CAGR of +37.2% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +7.2% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for AGL.
Why does AGL's quarterly revenue fluctuate?
AGL quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Agilon Health, Inc.'s revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is AGL's revenue distributed by segment?
AGL reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does AGL's revenue compare to industry peers?
Agilon Health, Inc. (AGL) with TTM revenue of $5.9B and +7.2% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.